Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with BBOT: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
BBOT
BridgeBio Oncology Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
BBOT
BridgeBio Oncology Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
LLY
ELI Lilly & Co
Change
1,407.25
▼
−0.27%
· post 1,411.60
· delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
BBOT
BridgeBio Oncology Therapeutics, Inc.
Change
2.33
▲
+0.68%
· post 2.28
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$184.9M
Revenue
—
Revenue
—
vs
Compare
After hours
Nov 3 '26
delayed
LLY
ELI Lilly & Co
vs
BBOT
BridgeBio Oncology Therapeutics, Inc.
1,407.25
▼
−0.27%
post 1,411.60
delayed
Price
2.33
▲
+0.68%
post 2.28
delayed
$1.3T
Mkt cap
$184.9M
Q3 FY26
$24.4B
Revenue
—
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,407.25
▼
−0.27%
vs
BBOT
2.33
▲
+0.68%
After hours
Nov 3 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
BBOT: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
BBOT, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No shared counterparties.
Only BBOT
2
LDOS
Leidos Biomedical Research
supplier
—
Lawrence Livermore National Security, LLC (LLNS)
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR